Can Fite Biofarma (Can Fite Biofarma) Median PS Value

: $0.00 (As of Today)

View and export this data going back to 2012. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Can Fite Biofarma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.177. Can Fite Biofarma's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-04-18), Can Fite Biofarma's share price is $1.97. Can Fite Biofarma's Median PS Value is $0.00. Therefore, Can Fite Biofarma's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Can Fite Biofarma's Median PS Value or its related term are showing as below:

CANF's Price-to-Median-PS-Value is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.655
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Can Fite Biofarma Median PS Value Historical Data

The historical data trend for Can Fite Biofarma's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can Fite Biofarma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Median PS Value

Can Fite Biofarma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Median PS Value																-	-	-	-	-

Competitive Comparison

For the Biotechnology subindustry, Can Fite Biofarma's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Can Fite Biofarma Price-to-Median-PS-Value Distribution

For the Biotechnology industry and Healthcare sector, Can Fite Biofarma's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Can Fite Biofarma's Price-to-Median-PS-Value falls into.

Can Fite Biofarma Median PS Value Calculation

Can Fite Biofarma's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0.177	*	0
	=	0.00

10-Year Median PS Ratio is 0.
Can Fite Biofarma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.177.

Can Fite Biofarma (AMEX:CANF) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Can Fite Biofarma's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	1.97	/	0.00
	=

Can Fite Biofarma Median PS Value Related Terms

Thank you for viewing the detailed overview of Can Fite Biofarma's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Can Fite Biofarma (Can Fite Biofarma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Can Fite Biofarma Ltd (AMEX:CANF) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

CANF:Israel

Address

10 Bareket Street, Kiryat Matalon, P.O. Box 7537, Petah-Tikva, ISR, 4951778

Website

http://www.canfite.com

Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).